Viamet Pharmaceuticals Funding: $178M Raised, Series D
Viamet Pharmaceuticals is based in Durham, NC. It has raised $178M in total funding. Latest round: Series D.
Viamet Pharmaceuticals funding overview
Viamet Pharmaceuticals is based in Durham, NC. Viamet Pharmaceuticals has raised $178M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in October 2014. The round record for Viamet Pharmaceuticals runs through 2014; nothing later has been disclosed. Investors on record include Brandon Point Industries Limited, Woodford Investment Management, Novartis Venture Fund, Lilly Ventures, Hatteras Venture Partners, Intersouth Partners and 2 others. 8 distinct backers are named across the disclosed rounds.
Frequently asked about Viamet Pharmaceuticals funding
How much has Viamet Pharmaceuticals raised?
Viamet Pharmaceuticals has raised $178M in total disclosed funding across the rounds on record.
Who has invested in Viamet Pharmaceuticals?
Brandon Point Industries Limited, Woodford Investment Management, Novartis Venture Fund, Lilly Ventures, Hatteras Venture Partners, Intersouth Partners are named among the investors backing Viamet Pharmaceuticals.
What was the latest Viamet Pharmaceuticals funding round?
The most recent disclosed round is a Series D, announced in October 2014.
Where is Viamet Pharmaceuticals based?
Viamet Pharmaceuticals is based in Durham, NC.
When did Viamet Pharmaceuticals last raise?
The last disclosed Viamet Pharmaceuticals round closed in October 2014 at Series D.
Totals shown for Viamet Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Durham and the investors behind them below.
